The consortium is established in an international collaboration of institutions from UK, India, Sri Lanka, Pakistan, The Netherlands and Finland.
The Consortium includes experts in the epidemiology of Type-2 Diabetes, health promotion and health policy in the context of obesity and T2D at local, national and international level, statistical analysis, health economics.
iHealth-T2D is coordinated by the Department of Epidemiology and Biostatistics, at Imperial College London. Prof John Chambers is the Chief Investigator and Ninha Silva is the Project Manager.
In addition, the project management team includes a Regional Project Coordinator, based at Devki Devi Foundation, in India, and three Regional Clinical Trial Coordinator, each based in India, Pakistan and Sri Lanka.
A list of partner institutions and their respective lead investigators, is shown below. Visit Recruitment Teams page to learn more about the teams directly involved in the recruitment and intervention components of the study.
|Participating organisation||Short name||Country||Lead investigator|
|Imperial College London||Imperial||United Kingdom||Prof John Chambers|
|Devki Devi Foundation||DDF||India||Dr Sujeet Jha|
|University of Colombo||UCOL||Sri Lanka||Dr Prasad Katalunda|
|University of Kelaniya||UKEL||Sri Lanka||Prof Raj Wickremasinghe|
|University of Surrey||SURREY||United Kingdom||Prof Helen Gage|
|Ealing Hospital NHS Trust||EHT||United Kingdom||Prof Jaspal S Kooner|
|Institute of Health Policy||IHP||Sri Lanka||Dr Ravindra Rannan-Eliya|
|University of Amsterdam||AMC||The Netherlands||Dr Karien Stronks|
|University of Oulu||OULU||Finland||Prof MR Jarvelin|
|Punjab Institute of Cardiology||PIC||Pakistan||Dr Sajjad Ahmed|
|Services Institute of Medical Sciences||SIMS||Pakistan||Dr Khadija I Khawaja|